BridgeMD
New treatment option for Lung Cancer
Official title Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)
ClinicalTrials.gov ID: NCT01786590
What this study is testing
- What it's testing
- It is reported that more than 90,000 patients died of lung cancer and more than 20% of them were older than 80 years in North America. Therefore a less invasive but effective treatment is required for patients with lung cancer of advanced age, diminished pulmonary functions, and chronic diseases.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older
- Patients with confirmed lung cancer who require EBUS-TBNA as part of their staging investigations of the mediastinum and hilum prior to SBRT
- Performance status score (WHO/ECOG) of 0-2.
- Cytological or histological proof of non-small cell cancer
- Stage T1-2 disease, with no evidence of distant metastasis
You likely can't join if
- Patients who are deemed on clinical grounds not to be medically fit for a bronchoscopy
- Active systemic, pulmonary, or pericardial infection
- Patients who are pregnant or lactating
- Patients with plans to receive conventional radiotherapy, chemotherapy, biological therapy, vaccine therapy, or surgery as treatment (except at...
- Inability to give informed consent
See the full eligibility criteria
- Age 18 years or older
- Patients with confirmed lung cancer who require EBUS-TBNA as part of their staging investigations of the mediastinum and hilum prior to SBRT
- Performance status score (WHO/ECOG) of 0-2.
- Cytological or histological proof of non-small cell cancer
- Stage T1-2 disease, with no evidence of distant metastasis
- Patients are screened by both computed tomography (CT) and positron emission tomography (PET)
- Medically inoperable for surgical resection
- Patients who refused surgery
- Patients who are deemed on clinical grounds not to be medically fit for a bronchoscopy
- Active systemic, pulmonary, or pericardial infection
- Patients who are pregnant or lactating
- Patients with plans to receive conventional radiotherapy, chemotherapy, biological therapy, vaccine therapy, or surgery as treatment (except at disease progression).
- Inability to give informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.